Pristiq FDA Approval History
FDA Approved: Yes (First approved February 29, 2008)
Brand name: Pristiq
Generic name: desvenlafaxine
Dosage form: Extended-Release Tablets
Company: Wyeth Pharmaceuticals
Treatment for: Depression
Pristiq (desvenlafaxine) is a serotonin-norepinephrine reuptake inhibitor (SNRI) approved for the treatment for adult patients with major depressive disorder. Pristiq is also currently under review as a treatment for moderate-to-severe vasomotor symptoms associated with menopause.
Development Timeline for Pristiq
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.